1,2,3,4,5,6,7,8,9,10,11,13,14,15-Tetradecahydrocyclopenta[a]phenanthren-12-one

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: 1,2,3,4,5,6,7,8,9,10,11,13,14,15-Tetradecahydrocyclopenta[a]phenanthren-12-one
• 英文别名: 1,2,3,4,5,6,7,8,9,10,11,13,14,15-tetradecahydrocyclopenta[a]phenanthren-12-one
• 化学式: C₁₇H₂₄O
• 分子量: 244.37
• InChiKey: NEAYGVQSZHSXNM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  18
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• [EN] INHIBITORS OF GLUCOCORTICOID RECEPTOR<br/>[FR] INHIBITEURS DE RÉCEPTEURS GLUCOCORTICOÏDES
  申请人：ORIC PHARMACEUTICALS INC

  公开号：WO2017112909A1

  公开（公告）日：2017-06-29

  The present invention relates generally to compositions and methods for treating cancer and hypercortisolism. Provided herein are substituted steroidal derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of glucocorticoid receptors. Furthermore, the subject compounds and compositions are useful for the treatment of cancer and hypercortisolism.

  本发明一般涉及治疗癌症和高皮质醇血症的组合物和方法。本文提供了替代类固醇衍生物化合物和包含该类化合物的药物组合物。所述化合物和组合物对于抑制糖皮质激素受体是有用的。此外，所述化合物和组合物对于治疗癌症和高皮质醇血症是有用的。
• [EN] HEXADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE DERIVATIVES USEFUL IN TREATING PAIN AND INFLAMMATION<br/>[FR] DÉRIVÉS D'HEXADÉCAHYDRO-1 H-CYCLOPENTA [A]PHÉNANTHRÈNE UTILES DANS LE TRAITEMENT DE LA DOULEUR ET DE L'INFLAMMATION
  申请人：AQUINOX PHARMACEUTICALS CANADA INC

  公开号：WO2019195692A1

  公开（公告）日：2019-10-10

  wherein,R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.

  其中，R1、R2、R3、R4a、R4b和R5在本文中有所描述，或其立体异构体、对映体、互变异构体或混合物，或其药用可接受盐或溶剂化物，在本文中也有描述，以及其他化合物。这些化合物在治疗炎症和/或疼痛方面有用。还披露了包含本发明化合物的组合物，以及使用这些化合物治疗炎症和/或疼痛的方法。
• [EN] INDENE DERIVATIVES USEFUL IN TREATING PAIN AND INFLAMMATION<br/>[FR] DÉRIVÉS D'INDÈNE UTILES DANS LE TRAITEMENT DE LA DOULEUR ET DE L'INFLAMMATION
  申请人：AQUINOX PHARMACEUTICALS CANADA INC

  公开号：WO2019195777A1

  公开（公告）日：2019-10-10

  Compounds of formula (I): wherein,R1, R2, R3, R4a, R4b and R5 are described herein, or a stereoisomer, enantiomer or tautomer thereof or mixtures thereof, or a pharmaceutically acceptable salt or solvate thereof, are described herein, as well as other compounds. These compounds are useful in treating inflammation and/or pain. Compositions comprising a compound of the invention are also disclosed, as are methods of using the compounds to treat inflammation and/or pain.

  公式(I)的化合物：其中，R1、R2、R3、R4a、R4b和R5如本文所述，或其立体异构体、对映体、互变异构体或其混合物，或其药用可接受的盐或溶剂化物，也如本文所述，以及其他化合物。这些化合物在治疗炎症和/或疼痛方面是有用的。还披露了包含本发明化合物的组合物，以及使用这些化合物治疗炎症和/或疼痛的方法。
• [EN] HUMAN GHRELIN O-ACYL TRANSFERASE INHIBITORS<br/>[FR] INHIBITEURS DE LA GHRÉLINE O-ACYL TRANSFÉRASE HUMAINE
  申请人：HOUGLAND JAMES L

  公开号：WO2018035079A1

  公开（公告）日：2018-02-22

  A class of cyanosteroid compounds that efficiently inhibit ghrelin acylation by ghrelin O-acyltransferase. The compounds have a steroid scaffold with α,β-unsaturated ketone in the A ring position such an a-cyanoenone. Exemplary compounds include (5S,8S,9S,10S, 13S,14S)-10,13-dimethyl-3-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17- tetradecahydro-3H-cyclopenta[a]phenanthrene-2-carbonitrile.

  一类氰基类固醇化合物，能有效抑制胃泌素O-酰基转移酶对胃泌素的酰化作用。这些化合物具有类固醇骨架，A环位置带有α，β-不饱和酮，如α-氰基烯酮。示例化合物包括(5S,8S,9S,10S,13S,14S)-10,13-二甲基-3-氧代-4,5,6,7,8,9,10,11,12,13,14,15,16,17-十四氢-3H-环戊[a]苯并-2-碳腈。
• NOVEL COMPOUNDS OF 11BETA-HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION OR DEPLETION
  申请人：Sphaera Pharma Pvt. Ltd.

  公开号：EP2948152A2

  公开（公告）日：2015-12-02